A point of view on hereditary thrombophilia and low-molecular-weight heparin incorporating the management in pregnancy and involving thyroidology
- PMID: 37729383
- PMCID: PMC10508948
- DOI: 10.1590/1806-9282.20230735
A point of view on hereditary thrombophilia and low-molecular-weight heparin incorporating the management in pregnancy and involving thyroidology
Conflict of interest statement
Conflicts of interest: the authors declare there is no conflicts of interest.
References
-
- Dugalic S, Petronijevic M,, Sengul D, Detanac DA, Sengul I, Veiga ECA, et al. Hereditary thrombophilia and low-molecular-weight heparin in women: useful determinants, including thyroid dysfunction, incorporating the management of treatment and outcomes of the entity. Rev Assoc Med Bras (1992). 2023;69((2)):335–40. doi: 10.1590/1806-9282.20221445. - DOI - PMC - PubMed
-
- Gojnic MG, Dugalic SV, Stefanovic AO, Stefanovic KV, Petronijevic MA, Vrzic Petronijevic SM, et al. Combined hereditary thrombophilias are responsible for poor placental vascularization development and low molecular weight heparins (LMWH) prevent adverse pregnancy outcomes in these patients. J Matern Fetal Neonatal Med. 2022;35((22)):4346–53. doi: 10.1080/14767058.2020.1849116. - DOI - PubMed
-
- Hadžić D, Zulić E, Alihodžić H, Softić D, Kovačevic D. Oxygen saturation index for assessment of respiratory failure in neonates. Sanamed. 2018;13((2)):123–9. doi: 10.24125/sanamed.v13i2.224. - DOI
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
